Biodiversity, Shapley value and phylogenetic trees: some remarks
Abstract
This paper explores the main differences between the Shapley values of a set of taxa introduced by Haake et al. (J Math Biol 56:479-497, 2007. https://doi.org/10.1007/s00285-007-0126-2) and Fuchs and Jin (J Math Biol 71:1133-1147, 2015. https://doi.org/10.1007/s00285-014-0853-0), the latter having been found identical to the Fair Proportion index (Redding and Mooers in Conserv Biol 20:1670-1678, 2006. https://doi.org/10.1111/j.1523-1739.2006.00555.x). In line with Shapley (in: Kuhn, Tucker (eds) Contributions to to the theory of games, volume II, annals of mathematics studies 28, Princeton University Press, Princeton, 1953), we identify the cooperative game basis for each of these two classes of phylogenetic games and use them (i) to construct simple formulas for these two Shapley values and (ii) to compare these different approaches. Using the set of weights of a phylogenetic tree as a parameter space, we then discuss the conditions under which these two values coincide and, if they are not the same, revisit Hartmann's (J Math Biol 67:1163-1170, 2013. https://doi.org/10.1007/s00285-012-0585-y) convergence result. An example illustrates our main argument. Finally, we compare the species ranking induced by these two values. Considering the Kendall and the Spearman rank correlation coefficient, simulations show that these rankings are strongly correlated. These results are consistent with Wicke and Fischer (J Theor Biol 430:207-214, 2017.…
How strong is the evidence?
Evidence Hub reads this as a simulation / modelling, done in computer models (in silico), not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.